{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T07:09:15Z","timestamp":1763363355532,"version":"3.45.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23262-x","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:31:18Z","timestamp":1762972278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heart rate management using ivabradine in acute myocardial infarction: a propensity score-matched single-center study"],"prefix":"10.1038","volume":"15","author":[{"given":"Meixian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiqi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhurong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daqian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"23262_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7150\/ijms.64984","volume":"19","author":"FF Ramli","year":"2022","unstructured":"Ramli, F. F., Ali, A. & Ibrahim, N. Molecular-Signaling pathways of ginsenosides Rb in myocardial Ischemia-Reperfusion injury: A mini review. Int. J. Med. Sci. 19, 65\u201373. https:\/\/doi.org\/10.7150\/ijms.64984 (2022).","journal-title":"Int. J. Med. Sci."},{"key":"23262_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0140-6736(08)61237-4","volume":"372","author":"HD White","year":"2008","unstructured":"White, H. D. & Chew, D. P. Acute myocardial infarction. Lancet 372, 570\u2013584. https:\/\/doi.org\/10.1016\/S0140-6736(08)61237-4 (2008).","journal-title":"Lancet"},{"key":"23262_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 394, 1145\u20131158. https:\/\/doi.org\/10.1016\/S0140-6736(19)30427-1 (2019).","journal-title":"Lancet"},{"key":"23262_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10557-016-6653-6","volume":"30","author":"EB Levitan","year":"2016","unstructured":"Levitan, E. B. et al. Burden of coronary heart disease rehospitalizations following acute myocardial infarction in older adults. Cardiovasc. Drugs Ther. 30, 323\u2013331. https:\/\/doi.org\/10.1007\/s10557-016-6653-6 (2016).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"23262_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.cjco.2024.02.001","volume":"6","author":"VH Tran","year":"2024","unstructured":"Tran, V. H. et al. Ventricular tachycardia and hospital readmission in patients discharged from the hospital after an acute myocardial infarction. CJC Open. 6, 781\u2013789. https:\/\/doi.org\/10.1016\/j.cjco.2024.02.001 (2024).","journal-title":"CJC Open."},{"key":"23262_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.amjcard.2015.12.006","volume":"117","author":"HY Chen","year":"2016","unstructured":"Chen, H. Y., Tisminetzky, M., Yarzebski, J., Gore, J. M. & Goldberg, R. J. Decade-Long trends in the frequency of 90-Day rehospitalizations after hospital discharge for acute myocardial infarction. Am. J. Cardiol. 117, 743\u2013748. https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.006 (2016).","journal-title":"Am. J. Cardiol."},{"key":"23262_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ahj.2011.08.002","volume":"162","author":"DJ Kelly","year":"2011","unstructured":"Kelly, D. J. et al. Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Am. Heart J. 162, 663\u2013670. https:\/\/doi.org\/10.1016\/j.ahj.2011.08.002 (2011).","journal-title":"Am. Heart J."},{"key":"23262_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10654-006-9087-9","volume":"22","author":"G Gouya","year":"2007","unstructured":"Gouya, G., Reichardt, B., Ohrenberger, G. & Wolzt, M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur. J. Epidemiol. 22, 145\u2013149. https:\/\/doi.org\/10.1007\/s10654-006-9087-9 (2007).","journal-title":"Eur. J. Epidemiol."},{"key":"23262_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijcard.2015.04.177","volume":"190","author":"F Er","year":"2015","unstructured":"Er, F. et al. Esmolol for tight heart rate control in patients with STEMI: design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial. Int. J. Cardiol. 190, 351\u2013352. https:\/\/doi.org\/10.1016\/j.ijcard.2015.04.177 (2015).","journal-title":"Int. J. Cardiol."},{"key":"23262_CR10","doi-asserted-by":"publisher","first-page":"e020012","DOI":"10.1161\/JAHA.120.020012","volume":"10","author":"Y Tamaki","year":"2021","unstructured":"Tamaki, Y. et al. Lower In-Hospital mortality with Beta-Blocker use at admission in patients with acute decompensated heart failure. J. Am. Heart Assoc. 10, e020012. https:\/\/doi.org\/10.1161\/JAHA.120.020012 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"23262_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1536\/ihj.21-355","volume":"62","author":"T Imamura","year":"2021","unstructured":"Imamura, T. & Kinugawa, K. Optimal heart rate modulation using ivabradine. Int. Heart J. 62, 717\u2013721. https:\/\/doi.org\/10.1536\/ihj.21-355 (2021).","journal-title":"Int. Heart J."},{"key":"23262_CR12","doi-asserted-by":"publisher","unstructured":"Kamisah, Y. & Che Hassan, H. H. Therapeutic use and molecular aspects of ivabradine in cardiac remodeling: A review. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24032801 (2023).","DOI":"10.3390\/ijms24032801"},{"key":"23262_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4330\/wjc.v9.i2.182","volume":"9","author":"M Anantha Narayanan","year":"2017","unstructured":"Anantha Narayanan, M. et al. Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis. World J. Cardiol. 9, 182\u2013190. https:\/\/doi.org\/10.4330\/wjc.v9.i2.182 (2017).","journal-title":"World J. Cardiol."},{"key":"23262_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg, K. et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376, 875\u2013885. https:\/\/doi.org\/10.1016\/S0140-6736(10)61198-1 (2010).","journal-title":"Lancet"},{"key":"23262_CR15","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.ahjo.2022.100158","volume":"17","author":"JA Borovac","year":"2022","unstructured":"Borovac, J. A. et al. Clinical use of ivabradine in the acute coronary syndrome: A systematic review and narrative synthesis of current evidence. Am. Heart J. Plus. 17, 100158. https:\/\/doi.org\/10.1016\/j.ahjo.2022.100158 (2022).","journal-title":"Am. Heart J. Plus"},{"key":"23262_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12872-025-04854-x","volume":"25","author":"X Guo","year":"2025","unstructured":"Guo, X. et al. Long-term safety and efficacy of ivabradine after direct percutaneous coronary intervention in patients with acute myocardial infarction complicated by heart failure: a single-center retrospective study. BMC Cardiovasc. Disord. 25, 422. https:\/\/doi.org\/10.1186\/s12872-025-04854-x (2025).","journal-title":"BMC Cardiovasc. Disord"},{"key":"23262_CR17","doi-asserted-by":"publisher","first-page":"e000285","DOI":"10.1161\/JAHA.113.000285","volume":"3","author":"JI Hoffman","year":"2014","unstructured":"Hoffman, J. I. & Buckberg, G. D. The myocardial oxygen supply:demand index revisited. J. Am. Heart Assoc. 3, e000285. https:\/\/doi.org\/10.1161\/JAHA.113.000285 (2014).","journal-title":"J. Am. Heart Assoc."},{"key":"23262_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/s0735-1097(97)00527-5","volume":"31","author":"K Hu","year":"1998","unstructured":"Hu, K., Gaudron, P. & Ertl, G. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. J. Am. Coll. Cardiol. 31, 692\u2013700. https:\/\/doi.org\/10.1016\/s0735-1097(97)00527-5 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"23262_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ehf2.14581","volume":"11","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study. ESC Heart Fail. 11, 846\u2013858. https:\/\/doi.org\/10.1002\/ehf2.14581 (2024).","journal-title":"ESC Heart Fail."},{"key":"23262_CR20","doi-asserted-by":"publisher","unstructured":"Priti, K. et al. Ivabradine vs Metoprolol in patients with acute inferior wall myocardial infarction-Expanding arena for ivabradine. Cardiovasc. Ther. 35 https:\/\/doi.org\/10.1111\/1755-5922.12266 (2017).","DOI":"10.1111\/1755-5922.12266"},{"key":"23262_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ehjcvp\/pvaa029","volume":"7","author":"SJ Joo","year":"2021","unstructured":"Joo, S. J. et al. Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction. Eur. Heart J. Cardiovasc. Pharmacother. 7, 475\u2013482. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa029 (2021).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother"},{"key":"23262_CR22","doi-asserted-by":"publisher","first-page":"1560639","DOI":"10.3389\/fcvm.2025.1560639","volume":"12","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Efficacy of ivabradine in patients with poor heart rate control after beta-blocker use in acute myocardial infarction: a pragmatic randomized controlled trial. Front. Cardiovasc. Med. 12, 1560639. https:\/\/doi.org\/10.3389\/fcvm.2025.1560639 (2025).","journal-title":"Front. Cardiovasc. Med."},{"key":"23262_CR23","doi-asserted-by":"publisher","first-page":"e33779","DOI":"10.1016\/j.heliyon.2024.e33779","volume":"10","author":"R He","year":"2024","unstructured":"He, R. et al. Effect of the combined use of ivabradine and Metoprolol in patients with acute myocardial infarction early after percutaneous coronary intervention: A randomized controlled study. Heliyon 10, e33779. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33779 (2024).","journal-title":"Heliyon"},{"key":"23262_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000322905","volume":"117","author":"D Busseuil","year":"2010","unstructured":"Busseuil, D. et al. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. Cardiology 117, 234\u2013242. https:\/\/doi.org\/10.1159\/000322905 (2010).","journal-title":"Cardiology"},{"key":"23262_CR25","doi-asserted-by":"publisher","first-page":"696635","DOI":"10.3389\/fphar.2021.696635","volume":"12","author":"H Xie","year":"2021","unstructured":"Xie, H. et al. Ivabradine ameliorates cardiac diastolic dysfunction in diabetic mice independent of heart rate reduction. Front. Pharmacol. 12, 696635. https:\/\/doi.org\/10.3389\/fphar.2021.696635 (2021).","journal-title":"Front. Pharmacol."},{"key":"23262_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4068\/cmj.2018.54.3.167","volume":"54","author":"HB Kim","year":"2018","unstructured":"Kim, H. B., Hong, Y. J., Park, H. J., Ahn, Y. & Jeong, M. H. Effects of ivabradine on left ventricular systolic function and cardiac fibrosis in rat myocardial Ischemia-Reperfusion model. Chonnam Med. J. 54, 167\u2013172. https:\/\/doi.org\/10.4068\/cmj.2018.54.3.167 (2018).","journal-title":"Chonnam Med. J."},{"key":"23262_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijcard.2017.02.046","volume":"236","author":"G Niccoli","year":"2017","unstructured":"Niccoli, G., Borovac, J. A., Vetrugno, V., Camici, P. G. & Crea, F. Ivabradine in acute coronary syndromes: protection beyond heart rate Lowering. Int. J. Cardiol. 236, 107\u2013112. https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.046 (2017).","journal-title":"Int. J. Cardiol."},{"key":"23262_CR28","doi-asserted-by":"publisher","unstructured":"Chinese guideline for percutaneous coronary. intervention. Zhonghua Xin Xue Guan Bing Za Zhi. 44, 382\u2013400. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3758.2016.05.006 (2016).","DOI":"10.3760\/cma.j.issn.0253-3758.2016.05.006"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23262-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T07:04:42Z","timestamp":1763363082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23262-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23262"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23262-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the 900th Hospital of PLA Joint Logistics Support Force (2018-001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}}],"article-number":"39645"}}